Largest companies by cash on hand
cash on hand
| Company | Cash on hand | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 1 | $13.99B | Healthcare | Biotechnology | United States | Nasdaq |
| 2 | $3.18B | Healthcare | Biotechnology | United States | Nasdaq |
| 3 | $1.72B | Healthcare | Biotechnology | United States | Nasdaq |
| 4 | $1.28B | Healthcare | Biotechnology | United States | Nasdaq |
| 5 | $815.43M | Healthcare | Biotechnology | United States | Nasdaq |
| 6 | $797.80M | Healthcare | Biotechnology | United States | Nasdaq |
| 7 | $606.78M | Healthcare | Biotechnology | United States | Nasdaq |
| 8 | $545.68M | Healthcare | Biotechnology | United States | Nasdaq |
| 9 | $455.41M | Healthcare | Biotechnology | United States | Nasdaq |
| 10 | $437.09M | Healthcare | Biotechnology | United States | Nasdaq |
| 11 | $427.74M | Healthcare | Biotechnology | United States | Nasdaq |
| 12 | $332.40M | Healthcare | Biotechnology | United States | Nasdaq |
| 13 | $291.34M | Healthcare | Biotechnology | United States | Nasdaq |
| 14 | $281.45M | Healthcare | Biotechnology | United States | Nasdaq |
| 15 | $278.73M | Healthcare | Biotechnology | United States | Nasdaq |
| 16 | $264.71M | Healthcare | Biotechnology | United States | Nasdaq |
| 17 | $237.37M | Healthcare | Biotechnology | United States | Nasdaq |
| 18 | $225.10M | Healthcare | Biotechnology | United States | Nasdaq |
| 19 | $205.13M | Healthcare | Biotechnology | United States | Nasdaq |
| 20 | $202.64M | Healthcare | Biotechnology | United States | Nasdaq |
| 21 | $201.56M | Healthcare | Biotechnology | United States | Nasdaq |
| 22 | $195.09M | Healthcare | Biotechnology | United States | Nasdaq |
| 23 | $191.46M | Healthcare | Biotechnology | United States | Nasdaq |
| 24 | $185.36M | Healthcare | Biotechnology | United States | Nasdaq |
| 25 | $183.19M | Healthcare | Biotechnology | United States | Nasdaq |
| 26 | $181.81M | Healthcare | Biotechnology | United States | Nasdaq |
| 27 | $169.87M | Healthcare | Biotechnology | United States | Nasdaq |
| 28 | $163.14M | Healthcare | Biotechnology | United States | Nasdaq |
| 29 | $160.08M | Healthcare | Biotechnology | United States | Nasdaq |
| 30 | $159.39M | Healthcare | Biotechnology | United States | Nasdaq |
| 31 | $154.97M | Healthcare | Biotechnology | United States | Nasdaq |
| 32 | $143.17M | Healthcare | Biotechnology | United States | Nasdaq |
| 33 | $142.61M | Healthcare | Biotechnology | United States | Nasdaq |
| 34 | $136.02M | Healthcare | Biotechnology | United States | Nasdaq |
| 35 | $133.34M | Healthcare | Biotechnology | United States | Nasdaq |
| 36 | $125.90M | Healthcare | Biotechnology | United States | Nasdaq |
| 37 | $125.17M | Healthcare | Biotechnology | United States | Nasdaq |
| 38 | $124.48M | Healthcare | Biotechnology | United States | Nasdaq |
| 39 | $121.19M | Healthcare | Biotechnology | United States | Nasdaq |
| 40 | $118.33M | Healthcare | Biotechnology | United States | Nasdaq |
| 41 | $117.44M | Healthcare | Biotechnology | United States | Nasdaq |
| 42 | $116.83M | Healthcare | Biotechnology | United States | Nasdaq |
| 43 | $115.98M | Healthcare | Biotechnology | United States | Nasdaq |
| 44 | $110.77M | Healthcare | Biotechnology | United States | Nasdaq |
| 45 | $101.89M | Healthcare | Biotechnology | United States | Nasdaq |
| 46 | $100.16M | Healthcare | Biotechnology | United States | Nasdaq |
| 47 | $100.05M | Healthcare | Biotechnology | United States | Nasdaq |
| 48 | $92.83M | Healthcare | Biotechnology | United States | Nasdaq |
| 49 | $90.10M | Healthcare | Biotechnology | United States | Nasdaq |
| 50 | $86.08M | Healthcare | Biotechnology | United States | Nasdaq |
| 51 | $82.92M | Healthcare | Biotechnology | United States | Nasdaq |
| 52 | $79.90M | Healthcare | Biotechnology | United States | Nasdaq |
| 53 | $78.64M | Healthcare | Biotechnology | United States | Nasdaq |
| 54 | $78.08M | Healthcare | Biotechnology | United States | Nasdaq |
| 55 | $75.67M | Healthcare | Biotechnology | United States | Nasdaq |
| 56 | $70.37M | Healthcare | Biotechnology | United States | Nasdaq |
| 57 | $64.11M | Healthcare | Biotechnology | United States | Nasdaq |
| 58 | $61.96M | Healthcare | Biotechnology | USA | Nasdaq |
| 59 | $59.91M | Healthcare | Biotechnology | United States | Nasdaq |
| 60 | $59.44M | Healthcare | Biotechnology | United States | Nasdaq |
| 61 | $54.34M | Healthcare | Biotechnology | United States | Nasdaq |
| 62 | $49.64M | Healthcare | Biotechnology | United States | Nasdaq |
| 63 | $43.17M | Healthcare | Biotechnology | United States | Nasdaq |
| 64 | $41.38M | Healthcare | Biotechnology | United States | Nasdaq |
| 65 | $41.25M | Healthcare | Biotechnology | United States | Nasdaq |
| 66 | $41.02M | Healthcare | Biotechnology | United States | Nasdaq |
| 67 | $38.63M | Healthcare | Biotechnology | United States | Nasdaq |
| 68 | $36.49M | Healthcare | Biotechnology | United States | Nasdaq |
| 69 | $35.77M | Healthcare | Biotechnology | United States | Nasdaq |
| 70 | $35.59M | Healthcare | Biotechnology | — | Nasdaq |
| 71 | $32.83M | Healthcare | Biotechnology | — | Nasdaq |
| 72 | $32.43M | Healthcare | Biotechnology | United States | Nasdaq |
| 73 | $32.32M | Healthcare | Biotechnology | United States | Nasdaq |
| 74 | $31.81M | Healthcare | Biotechnology | United States | Nasdaq |
| 75 | $30.38M | Healthcare | Biotechnology | United States | Nasdaq |
| 76 | $27.42M | Healthcare | Biotechnology | United States | NYSE |
| 77 | $26.19M | Healthcare | Biotechnology | United States | Nasdaq |
| 78 | $24.21M | Healthcare | Biotechnology | United States | Nasdaq |
| 79 | $23.95M | Healthcare | Biotechnology | United States | NYSE |
| 80 | $19.90M | Healthcare | Biotechnology | United States | Nasdaq |
| 81 | $19.64M | Healthcare | Biotechnology | United States | Nasdaq |
| 82 | $17.74M | Healthcare | Biotechnology | United States | Nasdaq |
| 83 | $17.08M | Healthcare | Biotechnology | United States | Nasdaq |
| 84 | $16.16M | Healthcare | Biotechnology | United States | Nasdaq |
| 85 | $11.31M | Healthcare | Biotechnology | United States | Nasdaq |
| 86 | $11.24M | Healthcare | Biotechnology | United States | Nasdaq |
| 87 | $9.53M | Healthcare | Biotechnology | United States | Nasdaq |
| 88 | $9.30M | Healthcare | Biotechnology | United States | Nasdaq |
| 89 | $9.20M | Healthcare | Biotechnology | United States | Nasdaq |
| 90 | $8.81M | Healthcare | Biotechnology | United States | Nasdaq |
| 91 | $8.27M | Healthcare | Biotechnology | United States | Nasdaq |
| 92 | $7.31M | Healthcare | Biotechnology | United States | Nasdaq |
| 93 | $6.96M | Healthcare | Biotechnology | USA | Nasdaq |
| 94 | $6.46M | Healthcare | Biotechnology | United States | Nasdaq |
| 95 | $5.65M | Healthcare | Biotechnology | United States | Nasdaq |
| 96 | $5.54M | Healthcare | Biotechnology | United States | Nasdaq |
| 97 | $5.07M | Healthcare | Biotechnology | United States | Nasdaq |
| 98 | $4.36M | Healthcare | Biotechnology | United States | Nasdaq |
| 99 | $4.12M | Healthcare | Biotechnology | United States | Nasdaq |
| 100 | $3.53M | Healthcare | Biotechnology | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 106 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.